FHTX - Foghorn Therapeutics Inc
IEX Last Trade
8.24
0.350 4.248%
Share volume: 106,337
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$7.89
0.35
4.44%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-03-09 | 2023-05-08 | 2023-08-04 | 2023-11-02 | 2024-03-07 | 2024-05-06 | |
| Total revenue | 4.490 M | 6.634 M | 4.184 M | 5.309 M | 5.599 M | 17.478 M | 5.769 M | 5.050 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 4.490 M | 6.634 M | 4.184 M | 5.309 M | 5.599 M | 17.478 M | 5.769 M | 5.050 M | |
| 47.75% | -36.93% | 26.89% | 5.46% | 212.16% | -66.99% | -12.46% | |||
| Operating expenses | 33.678 M | 34.893 M | 36.070 M | 38.626 M | 37.649 M | 34.559 M | 31.227 M | 33.244 M | |
| Selling general and admin | 7.704 M | 7.965 M | 7.862 M | 8.641 M | 8.401 M | 8.308 M | 7.022 M | 7.710 M | |
| Research and development | 25.974 M | 26.928 M | 28.208 M | 29.985 M | 29.248 M | 26.251 M | 24.205 M | 25.534 M | |
| Total expenses | 33.678 M | 34.893 M | 36.070 M | 38.626 M | 37.649 M | 34.559 M | 31.227 M | 33.244 M | |
| 3.61% | 3.37% | 7.09% | -2.53% | -8.21% | -9.64% | 6.46% | |||
| Operating income | -29.188 M | -28.259 M | -31.886 M | -33.317 M | -32.050 M | -17.081 M | -25.458 M | -28.194 M | |
| Ebit | -29.188 M | -28.259 M | -31.886 M | -33.317 M | -32.050 M | -17.081 M | -25.458 M | -28.194 M | |
| Pretax income | -27.313 M | -25.769 M | -28.886 M | -29.928 M | -28.545 M | -13.607 M | -22.120 M | -25.016 M | |
| -5.65% | 12.10% | 3.61% | -4.62% | -52.33% | 62.56% | 13.09% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 560.000 K | 942.000 K | 738.000 K | 1.986 M | 0.000 | |
| Net income basic | -27.313 M | -25.769 M | -28.886 M | -30.488 M | -29.487 M | -14.345 M | -24.106 M | -25.016 M | |
| 5.65% | -12.10% | -5.55% | 3.28% | 51.35% | -68.04% | -3.77% | |||
| Net income | -27.313 M | -25.769 M | -28.886 M | -30.488 M | -29.487 M | -14.345 M | -24.106 M | -25.016 M | |
| 5.65% | -12.10% | -5.55% | 3.28% | 51.35% | -68.04% | -3.77% |